Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

NCT07147309 is registered in ClinicalTrials.gov with Weibing Miao, PhD as lead sponsor.

NCT NCT07147309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07147309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy
Lead sponsor
Weibing Miao, PhD
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
September 1, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, fdg pet, microglial activation, pet / mr, synaptic vesicle proteins